Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 3, 2007, Pages 825-830

  Chen, Allen M ^a   Chang, Susan ^a   Pouliot, Jean ^a   Sneed, Penny K ^a   Prados, Michael D ^a   Lamborn, Kathleen R ^a   Malec, Mary K ^a   McDermott, Michael W ^a   Berger, Mitchell S ^a   Larson, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brachytherapy; Glioblastoma; Iodine 125; Radiotherapy

Indexed keywords

DOSIMETRY; ONCOLOGY; RADIOTHERAPY; TOXICITY;

BRACHYTHERAPY; GLIOBLASTOMA MULTIFORME; NECROSIS; RESECTION;

IODINE;

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; BRACHYTHERAPY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; GLIOBLASTOMA; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 34548703113     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.03.061     Document Type: Article

References (26)

1. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
2. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85 (1993) 704-710
3. Lamborn K.R., Chang S.M., and Prados M.D. Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis. Neuro-oncol 6 (2004) 227-235
4. Simpson J.R., Horton J., Scott C., et al. Influence of location and extent of surgical resection on survival of patients with multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26 (1993) 239-244
5. Wallner K.E., Galicich J.H., Krol G., et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16 (1989) 1405-1409
6. Garden A.S., Maor M.H., Yung W.K., et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 20 (1991) 99-110
7. Gaspar L.E., Fisher B.J., Macdonald D.R., et al. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24 (1992) 55-57
8. Salazar O.M., Rubin P., Feldstein M.L., et al. High dose radiation therapy in the treatment of malignant gliomas: Final report. Int J Radiat Oncol Biol Phys 5 (1979) 1733-1740
9. Walker M.D., Strike T.A., and Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5 (1979) 1725-1731
10. Bleehen N.M., and Stenning S.P. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64 (1991) 769-774
11. Selker R.G., Shapiro W.R., Burger P., et al. The Brain Tumor Cooperative Group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51 (2002) 343-355
12. Laperriere N.J., Leung P.M.K., McKenzie S., et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41 (1998) 1005-1011
13. Scharfen C.O., Sneed P.K., Wara W.M., et al. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24 (1992) 583-591
14. Halligan J.B., Stelzer K.J., Rostomily R.C., et al. Operation and permanent low activity I-125 brachytherapy for recurrent high grade astrocytomas. Int J Radiat Oncol Biol Phys 35 (1996) 541-547
15. Sneed P.K., Prados M.D., McDermott M.W., et al. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36 (1995) 898-904
16. Prados M.D., Gutin P.H., Phillips T.L., et al. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience. Int J Radiat Oncol Biol Phys 24 (1992) 593-597
17. Gutin P.H., Prados M.D., Phillips T.L., et al. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG Study 6G-82-2. Int J Radiat Oncol Biol Phys 21 (1991) 601-606
18. Larson D.A., Suplica J.M., Chang S.M., et al. Permanent iodine125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro-oncol 6 (2004) 119-126
19. Haas-Kogan D.A., Kogan S.S., Yount G., et al. P53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int J Radiat Oncol Biol Phys 2 (1999) 399-403
20. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
21. McDermott M.W., Gutin P.H., Larson D.A., et al. Interstitial brachytherapy. Neurosurg Clin North Am 1 (1990) 801-824
22. Wen P.Y., Alexander E.A., Black P.M., et al. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 73 (1994) 3029-3036
23. Fernandez P.M., Zamorano L., Yakar D., et al. Permanent iodine-125 implants in the up-front treatment of malignant glioma. Neurosurgery 36 (1995) 467-473
24. Schupak K., Malkin M., Anderson L., et al. The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. Int J Radiat Oncol Biol Phys 32 (1995) 1167-1176
25. Shrieve D.C., Alexander E., Wen P.Y., et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36 (1995) 275-282
26. Bernstein M., Laperriere N., Glen J., et al. Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys 30 (1994) 1213-1217